A federal judge in Rhode Island has issued a sweeping order preventing the Trump administration from cutting $11 billion in ...

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has released new data that sheds light on why ...

GSK’s (LSE: GSK) biologic therapy Nucala (mepolizumab) has demonstrated a consistent reduction in exacerbation rates among ...

After a prolonged wait, American company Novavax (Nasdaq: NVAX) has received full approval from the US regulator for its ...

Japanese drugmaker Chugai Pharmaceutical (TYO: 4519) today announced that it obtained regulatory approval from the Ministry ...

Emergency Task Force (EFT) has recommended updating COVID-19 vaccines to target the new SARS-CoV-2 variant LP.8.1 for the ...

Vaccines Europe’s response to the Call for Evidence on the European Centre for Disease Prevention and Control evaluation ...

Adopting a platform approach to designing new therapies will speed the delivery of innovative genomic treatments to ...

A clinical-stage biotech company developing fibrin-targeting immunotherapies for neurodegenerative and retinal diseases ...

Trade group Medicines Australia congratulates Mark Butler on his reappointment as the Minister for Health and Aging and for adding the portfolios of Disability and the National Disability Insurance ...

Pharmaceutical share prices fell last Monday, after US President Donald Trump vowed to reduce drug prices in the USA by as ...

Government price setting policies like Most Favored Nation are a bad deal for American patients. The “Foreign First Pricing” ...